These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19485918)

  • 1. Selective removal of macrophages in atherosclerotic plaques as a pharmacological approach for plaque stabilization: benefits versus potential complications.
    Croons V; Martinet W; De Meyer GR
    Curr Vasc Pharmacol; 2010 Jul; 8(4):495-508. PubMed ID: 19485918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective depletion of macrophages in atherosclerotic plaques via macrophage-specific initiation of cell death.
    Martinet W; Verheye S; De Meyer GR
    Trends Cardiovasc Med; 2007 Feb; 17(2):69-75. PubMed ID: 17292050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture.
    Boyle JJ
    Curr Vasc Pharmacol; 2005 Jan; 3(1):63-8. PubMed ID: 15638783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus-induced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy.
    Martinet W; Verheye S; De Meyer GR
    Autophagy; 2007; 3(3):241-4. PubMed ID: 17224626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
    Johnson JL
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages but not smooth muscle cells undergo benzyloxycarbonyl-Val-Ala-DL-Asp(O-Methyl)-fluoromethylketone-induced nonapoptotic cell death depending on receptor-interacting protein 1 expression: implications for the stabilization of macrophage-rich atherosclerotic plaques.
    Martinet W; De Meyer GR; Timmermans JP; Herman AG; Kockx MM
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1356-64. PubMed ID: 16537794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?
    Akdim F; van Leuven SI; Kastelein JJ; Stroes ES
    Curr Pharm Des; 2007; 13(10):1003-12. PubMed ID: 17430164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase.
    Croons V; Martinet W; Herman AG; Timmermans JP; De Meyer GR
    J Pharmacol Exp Ther; 2009 Jun; 329(3):856-64. PubMed ID: 19286921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective clearance of macrophages in atherosclerotic plaques by autophagy.
    Verheye S; Martinet W; Kockx MM; Knaapen MW; Salu K; Timmermans JP; Ellis JT; Kilpatrick DL; De Meyer GR
    J Am Coll Cardiol; 2007 Feb; 49(6):706-15. PubMed ID: 17291937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins.
    Shiomi M; Koike T; Ito T
    Atherosclerosis; 2013 Nov; 231(1):39-47. PubMed ID: 24125408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide selectively depletes macrophages in atherosclerotic plaques via induction of endoplasmic reticulum stress.
    Martinet W; Croons V; Timmermans JP; Herman AG; De Meyer GR
    Br J Pharmacol; 2007 Oct; 152(4):493-500. PubMed ID: 17700714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. z-VAD-fmk-induced non-apoptotic cell death of macrophages: possibilities and limitations for atherosclerotic plaque stabilization.
    Martinet W; Schrijvers DM; Herman AG; De Meyer GR
    Autophagy; 2006; 2(4):312-4. PubMed ID: 16874073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective clearance of macrophages in atherosclerotic plaques by the protein synthesis inhibitor cycloheximide.
    Croons V; Martinet W; Herman AG; Timmermans JP; De Meyer GR
    J Pharmacol Exp Ther; 2007 Mar; 320(3):986-93. PubMed ID: 17135342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis formation on atherosclerotic lesions and plaque rupture.
    Badimon L; Vilahur G
    J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque.
    Kowara M; Cudnoch-Jedrzejewska A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells.
    Yang JM; Dong M; Meng X; Zhao YX; Yang XY; Liu XL; Hao PP; Li JJ; Wang XP; Zhang K; Gao F; Zhao XQ; Zhang MX; Zhang Y; Zhang C
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1978-85. PubMed ID: 23723368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New insights into the etiopathogenesis of atherosclerosis and atherothrombosis].
    Herman AG
    Bull Mem Acad R Med Belg; 2006; 161(3-4):213-25; discussion 226-7. PubMed ID: 17172227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerotic plaque rupture and thrombosis. Evolving concepts.
    Fuster V; Stein B; Ambrose JA; Badimon L; Badimon JJ; Chesebro JH
    Circulation; 1990 Sep; 82(3 Suppl):II47-59. PubMed ID: 2203564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on acute coronary syndromes: the pathologists' view.
    Falk E; Nakano M; Bentzon JF; Finn AV; Virmani R
    Eur Heart J; 2013 Mar; 34(10):719-28. PubMed ID: 23242196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of apoptosis in atherosclerosis and its therapeutic implications.
    Stoneman VE; Bennett MR
    Clin Sci (Lond); 2004 Oct; 107(4):343-54. PubMed ID: 15230690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.